Glycoprotein pharmaceuticals: scientific and regulatory considerations, and the US Orphan Drug Act

This publication has 14 references indexed in Scilit:

• Pharmacokinetic properties of an escherichia-coli-produced recombinant plasminogen activator (BM 06.022) in rabbits
  Thrombosis Research, 1991
• Glycosylation of recombinant protein therapeutics: control and functional implications
  Glycobiology, 1991
• Pharmacokinetics and Coronary Thrombolytic Properties of Two Human Tissue-Type Plasminogen Activator Variants Lacking the Finger-Like, Growth Factor-Like, and First Kringle Domains (Amino Acids 6–173) in a Canine Model
  Journal of Cardiovascular Pharmacology, 1990
• IgE-, IgA- and IgG-antibody responses to carbohydrate and protein antigens of Candida albicans in asthmatic children
  Allergy, 1990
• N-Glycosylation and in vitro enzymic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line
  Biochemistry, 1989
• GLYCOBIOLOGY
  Annual Review of Biochemistry, 1988
• A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.
  Journal of Biological Chemistry, 1988
• Slow Clearance of Acylated, Hybrid Thrombolytic Enzymes
  Thrombosis and Haemostasis, 1988
• Structure and Biosynthesis of Plant N-Linked Glycoproteins
  Published by Elsevier ,1988
• Spatial structures of glycan chains of glycoproteins in relation to metabolism and function. Survey of a decade of research
  Published by Walter de Gruyter GmbH ,1984